Guo Li

Guo Li

Auto-generated profile, based on publicly available information

Guo Li

Xianghu Laboratory, Hangzhou, China.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
GLGuo Li
Guo Li
YCYaxian Cheng
Yaxian Cheng
JYJingwen Yu
Jingwen Yu
YZYunfei Zhu
Yunfei Zhu
HMHongru Ma
Hongru Ma
YYyuan yao
yuan yao

3 October 2024 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
HMHongru Ma
Hongru Ma
XZXinzhi Zhou
Xinzhi Zhou
ZZZiyue Zhang
Ziyue Zhang
ZWZhaocheng Weng
Zhaocheng Weng
GLGuo Li
Guo Li
YYyuan yao
yuan yao

1 March 2020 in Journal of Genetics and Genomics
Verified
Journal Article
Open access
GLGuo Li
Guo Li
XWXinjie Wang
Xinjie Wang
YLYajing Liu
Yajing Liu
XLXinyuan Lv
Xinyuan Lv
GLGuanglei Li
Guanglei Li
XHXiaoxiang Hu
Xiaoxiang Hu
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

27 June 2026 in Cell Communication and Signaling
Verified
Journal Article
Open access
GLGuo Li
Guo Li
XZXinzhi Zhou
Xinzhi Zhou
GZGuanglin Zhu
Guanglin Zhu
YCYaxian Cheng
Yaxian Cheng
YPYingjia Pan
Yingjia Pan
WJWen Jiang
Wen Jiang
Mitochondrial epigenetic editing offers a potential strategy for modulating disease-causing mitochondrial genes while leaving the underlying DNA sequence unchanged. In this study, we present MEE, a mitochondrial epigenetic editor consisting of mitochondrion-targeted TALE modules fused to Dnmt3A and Dnmt3L methyltransferases. MEE efficiently directed site-specific 5mC methylation within cellular mitochondrial DNA with low detectable off-target activity under the tested conditions. MEE-mediated methylation at the C12191 (H) site exceeded 53% and was associated with an approximately 95% reduction in steady-state MT-ND5 mRNA levels in human cells. Notably, MEE increased methylation at the aging-associated C11168 (H) site by 11.76% in vivo, leading to reduced MT-ND4 expression in the targeted brain region and altered plasma levels of t-Tau and NFL in mice. These findings demonstrate that MEE provides a tool for precise epigenetic engineering of mitochondrial DNA, enabling experimental interrogation of specific 5mC modifications and exploration of the functional roles of mitochondrial DNA methylation in aging-associated diseases.